Inhibitor Report for: E2030
E2030 | Type | Pyridine |
| | Boron compound |
| Other_Name | E-2030 |
| | 3-(2-(1-(1,3-dioxolan-2-ylmethyl)-4-piperidyl)ethyl)-2H-3,4-dihydro-1,3-benzoxazin-2,4-dione hydrochloride |
| Chemical_Nomenclature | [2-methoxy-5-[(E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethenyl]pyridin-4-yl]methanamine |
| Formula | C15H23BN2O3 |
| MW | 290.16 |
|  |
| Paper | Ogura_2001_Eur.J.Pharmacol_415_157 |
| CID | 74890773 |
| Family | ACHE |
| | BCHE |
| InChIKey | LAGBVTUFYIBFIX-VOTSOKGWSA-N |
| CanonicalSMILES | B1(OC(C(O1)(C)C)(C)C)C=CC2=CN=C(C=C2CN)OC |
| InChI | InChI=1S/C15H23BN2O3/c1-14(2)15(3,4)21-16(20-14)7-6-11-10-18-13(19-5)8-12(11)9-17/h6-8,10H,9,17H2,1-5H3/b7-6+ |
|
|